Sodium–Glucose Cotransporter 2 Inhibitors and Major COVID-19 Outcomes: Promising Mechanisms, Conflicting Data, and Intriguing Clinical Decisions

Sodium–Glucose Cotransporter 2 Inhibitors and Major COVID-19 Outcomes: Promising Mechanisms, Conflicting Data, and Intriguing Clinical Decisions

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Diabetes therapy 2020-12, Vol.11 (12), p.3003-3005
Hauptverfasser: Patoulias, Dimitrios, Papadopoulos, Christodoulos, Katsimardou, Alexandra, Toumpourleka, Maria, Doumas, Michael
Format: Artikel
Sprache:eng
Schlagworte:
Cardiology
Diabetes
Endocrinology
Internal Medicine
Letter
Medicine
Medicine & Public Health
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 3005
container_issue 12
container_start_page 3003
container_title Diabetes therapy
container_volume 11
creator Patoulias, Dimitrios
Papadopoulos, Christodoulos
Katsimardou, Alexandra
Toumpourleka, Maria
Doumas, Michael
description
doi_str_mv 10.1007/s13300-020-00942-7
format Article
fullrecord <record><control><sourceid>gale_pubme</sourceid><recordid>TN_cdi_gale_infotracacademiconefile_A651344855</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A651344855</galeid><sourcerecordid>A651344855</sourcerecordid><originalsourceid>FETCH-LOGICAL-c541t-912f2df37daf44ac054c95b25f4de2d090ce3be9784594edf6054677b52efb253</originalsourceid><addsrcrecordid>eNp9Ustu1DAUjRCIVqU_wAJFYsOiKX4mMQukKgNlpFaDxGNreZzrGY8Se2onSOz4h_4A38Kn8CU4nTKlCGHLsnXvOUf3Xp8se4rRKUaoehkxpQgViKSDBCNF9SA7xHUpilKU-OH-zelBdhzjBqVFhRAYP84OEpUTTuvD7PqDb-3Y__x2fd6N2kfIGz8E5eLWhwHCj-8kn7u1XdrBh5gr1-aXauND3iw-z2cFFvliHLTvIb7K3wff22jdKr8EvVbOxj6eJDlnOquHKT5Tgzq5EZm7IdjVOAWbzjqrVZfPQCe6d_FJ9sioLsLx7X2UfXr75mPzrrhYnM-bs4tCc4aHQmBiSGto1SrDmNKIMy34knDDWiAtEkgDXYKoasYFg9aUCVFW1ZITMAlGj7LXO93tuOyh1ZCKUp3cBtur8FV6ZeX9jLNrufJfZMV5yRlLAi9uBYK_GiEOMg1AQ9cpB36MkjCOMeUVrRP0-V_QjR-DS-1JwjGhNa-xuEOtVAfSOjP9hZ5E5VnJMWWs5lPdp_9Apd1Cb7V3YGyK3yOQHUEHH2MAs-8RIzm5Se7cJJOb5I2bZJVIz_6czp7y2zsJQHeAmFJuBeGupf_I_gJFg9a9</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2512385819</pqid></control><display><type>article</type><title>Sodium–Glucose Cotransporter 2 Inhibitors and Major COVID-19 Outcomes: Promising Mechanisms, Conflicting Data, and Intriguing Clinical Decisions</title><source>DOAJ Directory of Open Access Journals</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><source>Springer Nature OA Free Journals</source><creator>Patoulias, Dimitrios ; Papadopoulos, Christodoulos ; Katsimardou, Alexandra ; Toumpourleka, Maria ; Doumas, Michael</creator><creatorcontrib>Patoulias, Dimitrios ; Papadopoulos, Christodoulos ; Katsimardou, Alexandra ; Toumpourleka, Maria ; Doumas, Michael</creatorcontrib><identifier>ISSN: 1869-6953</identifier><identifier>EISSN: 1869-6961</identifier><identifier>DOI: 10.1007/s13300-020-00942-7</identifier><identifier>PMID: 33052538</identifier><language>eng</language><publisher>Cheshire: Springer Healthcare</publisher><subject>Cardiology ; Diabetes ; Endocrinology ; Internal Medicine ; Letter ; Medicine ; Medicine &amp; Public Health</subject><ispartof>Diabetes therapy, 2020-12, Vol.11 (12), p.3003-3005</ispartof><rights>The Author(s) 2020</rights><rights>COPYRIGHT 2020 Springer</rights><rights>The Author(s) 2020. This work is published under http://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c541t-912f2df37daf44ac054c95b25f4de2d090ce3be9784594edf6054677b52efb253</citedby><cites>FETCH-LOGICAL-c541t-912f2df37daf44ac054c95b25f4de2d090ce3be9784594edf6054677b52efb253</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7556544/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7556544/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,860,881,27901,27902,41096,42165,51551,53766,53768</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33052538$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Patoulias, Dimitrios</creatorcontrib><creatorcontrib>Papadopoulos, Christodoulos</creatorcontrib><creatorcontrib>Katsimardou, Alexandra</creatorcontrib><creatorcontrib>Toumpourleka, Maria</creatorcontrib><creatorcontrib>Doumas, Michael</creatorcontrib><title>Sodium–Glucose Cotransporter 2 Inhibitors and Major COVID-19 Outcomes: Promising Mechanisms, Conflicting Data, and Intriguing Clinical Decisions</title><title>Diabetes therapy</title><addtitle>Diabetes Ther</addtitle><addtitle>Diabetes Ther</addtitle><subject>Cardiology</subject><subject>Diabetes</subject><subject>Endocrinology</subject><subject>Internal Medicine</subject><subject>Letter</subject><subject>Medicine</subject><subject>Medicine &amp; Public Health</subject><issn>1869-6953</issn><issn>1869-6961</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>C6C</sourceid><sourceid>BENPR</sourceid><recordid>eNp9Ustu1DAUjRCIVqU_wAJFYsOiKX4mMQukKgNlpFaDxGNreZzrGY8Se2onSOz4h_4A38Kn8CU4nTKlCGHLsnXvOUf3Xp8se4rRKUaoehkxpQgViKSDBCNF9SA7xHUpilKU-OH-zelBdhzjBqVFhRAYP84OEpUTTuvD7PqDb-3Y__x2fd6N2kfIGz8E5eLWhwHCj-8kn7u1XdrBh5gr1-aXauND3iw-z2cFFvliHLTvIb7K3wff22jdKr8EvVbOxj6eJDlnOquHKT5Tgzq5EZm7IdjVOAWbzjqrVZfPQCe6d_FJ9sioLsLx7X2UfXr75mPzrrhYnM-bs4tCc4aHQmBiSGto1SrDmNKIMy34knDDWiAtEkgDXYKoasYFg9aUCVFW1ZITMAlGj7LXO93tuOyh1ZCKUp3cBtur8FV6ZeX9jLNrufJfZMV5yRlLAi9uBYK_GiEOMg1AQ9cpB36MkjCOMeUVrRP0-V_QjR-DS-1JwjGhNa-xuEOtVAfSOjP9hZ5E5VnJMWWs5lPdp_9Apd1Cb7V3YGyK3yOQHUEHH2MAs-8RIzm5Se7cJJOb5I2bZJVIz_6czp7y2zsJQHeAmFJuBeGupf_I_gJFg9a9</recordid><startdate>20201201</startdate><enddate>20201201</enddate><creator>Patoulias, Dimitrios</creator><creator>Papadopoulos, Christodoulos</creator><creator>Katsimardou, Alexandra</creator><creator>Toumpourleka, Maria</creator><creator>Doumas, Michael</creator><general>Springer Healthcare</general><general>Springer</general><general>Springer Nature B.V</general><scope>C6C</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>8AO</scope><scope>8C1</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>COVID</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9-</scope><scope>K9.</scope><scope>KB0</scope><scope>M0R</scope><scope>M0S</scope><scope>NAPCQ</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20201201</creationdate><title>Sodium–Glucose Cotransporter 2 Inhibitors and Major COVID-19 Outcomes: Promising Mechanisms, Conflicting Data, and Intriguing Clinical Decisions</title><author>Patoulias, Dimitrios ; Papadopoulos, Christodoulos ; Katsimardou, Alexandra ; Toumpourleka, Maria ; Doumas, Michael</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c541t-912f2df37daf44ac054c95b25f4de2d090ce3be9784594edf6054677b52efb253</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Cardiology</topic><topic>Diabetes</topic><topic>Endocrinology</topic><topic>Internal Medicine</topic><topic>Letter</topic><topic>Medicine</topic><topic>Medicine &amp; Public Health</topic><toplevel>online_resources</toplevel><creatorcontrib>Patoulias, Dimitrios</creatorcontrib><creatorcontrib>Papadopoulos, Christodoulos</creatorcontrib><creatorcontrib>Katsimardou, Alexandra</creatorcontrib><creatorcontrib>Toumpourleka, Maria</creatorcontrib><creatorcontrib>Doumas, Michael</creatorcontrib><collection>Springer Nature OA Free Journals</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Proquest Nursing &amp; Allied Health Source</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Coronavirus Research Database</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>Consumer Health Database (Alumni Edition)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Consumer Health Database</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Diabetes therapy</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Patoulias, Dimitrios</au><au>Papadopoulos, Christodoulos</au><au>Katsimardou, Alexandra</au><au>Toumpourleka, Maria</au><au>Doumas, Michael</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Sodium–Glucose Cotransporter 2 Inhibitors and Major COVID-19 Outcomes: Promising Mechanisms, Conflicting Data, and Intriguing Clinical Decisions</atitle><jtitle>Diabetes therapy</jtitle><stitle>Diabetes Ther</stitle><addtitle>Diabetes Ther</addtitle><date>2020-12-01</date><risdate>2020</risdate><volume>11</volume><issue>12</issue><spage>3003</spage><epage>3005</epage><pages>3003-3005</pages><issn>1869-6953</issn><eissn>1869-6961</eissn><cop>Cheshire</cop><pub>Springer Healthcare</pub><pmid>33052538</pmid><doi>10.1007/s13300-020-00942-7</doi><tpages>3</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1869-6953
ispartof Diabetes therapy, 2020-12, Vol.11 (12), p.3003-3005
issn 1869-6953
1869-6961
language eng
recordid cdi_gale_infotracacademiconefile_A651344855
source DOAJ Directory of Open Access Journals; EZB-FREE-00999 freely available EZB journals; PubMed Central; Springer Nature OA Free Journals
subjects Cardiology
Diabetes
Endocrinology
Internal Medicine
Letter
Medicine
Medicine & Public Health
title Sodium–Glucose Cotransporter 2 Inhibitors and Major COVID-19 Outcomes: Promising Mechanisms, Conflicting Data, and Intriguing Clinical Decisions
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-01T16%3A36%3A10IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Sodium%E2%80%93Glucose%20Cotransporter%C2%A02%20Inhibitors%20and%20Major%20COVID-19%20Outcomes:%20Promising%20Mechanisms,%20Conflicting%20Data,%20and%20Intriguing%20Clinical%20Decisions&rft.jtitle=Diabetes%20therapy&rft.au=Patoulias,%20Dimitrios&rft.date=2020-12-01&rft.volume=11&rft.issue=12&rft.spage=3003&rft.epage=3005&rft.pages=3003-3005&rft.issn=1869-6953&rft.eissn=1869-6961&rft_id=info:doi/10.1007/s13300-020-00942-7&rft_dat=%3Cgale_pubme%3EA651344855%3C/gale_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2512385819&rft_id=info:pmid/33052538&rft_galeid=A651344855&rfr_iscdi=true